Maternal mortality ‐ not reported · women with postpartum iron deficiency anaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fatigue ‐ not reported · women with postpartum iron deficiency anaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Persistent anaemia symptoms ‐ not reported · women with postpartum iron deficiency anaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Thromboembolic events ‐ not reported · women with postpartum iron deficiency anaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Maternal death · women with postpartum iron deficiency anaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fatigue ‐ not reported · women with postpartum iron deficiency anaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Persistent anaemia symptoms Reported by the women · women with postpartum iron deficiency anaemia
It is very uncertain whether intravenous iron with oral iron changes persistent anaemia symptoms ‐ 1 week Visual Analogue Scale ≥ 7 compared with oral iron (Comparison 6) (very low certainty).
3 findings from 1 review
RR 1.75 [0.56, 5.46]
1 study · 72 participants
Very low
RR 0.6 [0.15, 2.33]
1 study · 72 participants
Very low
RR 3 [0.33, 27.5]
1 study · 72 participants
Very low
Infections ‐ not reported · women with postpartum iron deficiency anaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Anaphylaxis or evidence of hypersensitivity Clinical assessment · women with postpartum iron deficiency anaemia
1 finding from 1 review
Vaginal birth within 24 hours · women in the third trimester for induction of labour.
Oral misoprostol showed no clear difference in vaginal birth within 24 hours compared with intravenous oxytocin (low certainty).
1 finding from 1 review
Caesarean section · women in the third trimester for induction of labour.
Oral misoprostol probably leads to lower caesarean section compared with intravenous oxytocin (moderate certainty).
1 finding from 1 review
Uterine hyperstimulation with fetal heart rate changes · women in the third trimester for induction of labour.
It is very uncertain whether oral misoprostol changes uterine hyperstimulation with fetal heart rate changes compared with intravenous oxytocin (very low certainty).
1 finding from 1 review
Oxytocin augmentation · women in the third trimester for induction of labour.
Oral misoprostol may leads to lower oxytocin augmentation compared with intravenous oxytocin (low certainty).
1 finding from 1 review
Uterine hyperstimulation without fetal heart rate changes · women in the third trimester for induction of labour.
It is very uncertain whether oral misoprostol changes uterine hyperstimulation without fetal heart rate changes compared with intravenous oxytocin (very low certainty).
1 finding from 1 review
Apgar score less than 7 at 5 minutes · women in the third trimester for induction of labour.
It is very uncertain whether oral misoprostol changes apgar score less than 7 at 5 minutes compared with intravenous oxytocin (very low certainty).
1 finding from 1 review
Admission to neonatal intensive care unit · women in the third trimester for induction of labour.
It is very uncertain whether oral misoprostol changes admission to neonatal intensive care unit compared with intravenous oxytocin (very low certainty).
1 finding from 1 review